To hear about similar clinical trials, please enter your email below
Trial Title:
Coenzyme Q10 and Dentoalveolar Cyst
NCT ID:
NCT05873673
Condition:
Cyst, Jaw
Conditions: Official terms:
Cysts
Ubiquinone
Coenzyme Q10
Study type:
Interventional
Study phase:
Phase 2
Overall status:
Not yet recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Treatment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Intervention:
Intervention type:
Drug
Intervention name:
Coenzyme Q10
Description:
cystic jaw defect filled with coenzyme Q10 gel
Arm group label:
coenzyme group
Intervention type:
Drug
Intervention name:
control group
Description:
cystic jaw defect filled with placebo gel
Arm group label:
control group
Summary:
10 patients in each group will undergo cyst removal under local anesthesia. After cyst
removal, the cystic cavity will be filled with placebo gel in the control group or
coenzyme gel in the coenzyme group.
Bone density and volume will be assessed by cone beam CT immediately postoperative and
6months later for all patients
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Adult patients with critical-size jaw cysts
- Medically stable
- No cystic lesion recurrence
Exclusion Criteria:
- Cystic lesion recurrence
- Medical problem
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Start date:
June 11, 2023
Completion date:
February 1, 2024
Lead sponsor:
Agency:
Fayoum University
Agency class:
Other
Source:
Fayoum University
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05873673
